Updates on the preoperative immunotherapy for triple-negative breast cancer

Producción científica: Editorial › revisión exhaustiva

Idioma original	English (US)
Número de artículo	17
Publicación	Translational Breast Cancer Research
Volumen	4
DOI	https://doi.org/10.21037/tbcr-23-16
Estado	Published - abr 30 2023
Publicado de forma externa	Sí

ASJC Scopus subject areas

@article{c0f39b12a2d84fb6bc5d88893cdbe79a,

title = "Updates on the preoperative immunotherapy for triple-negative breast cancer",

keywords = "Triple negative breast cancer (TNBC), immunotherapy, neoadjuvant, pembrolizumab",

author = "Hong Hu and Virginia Kaklamani",

year = "2023",

month = apr,

day = "30",

doi = "10.21037/tbcr-23-16",

language = "English (US)",

volume = "4",

journal = "Translational Breast Cancer Research",

issn = "2218-6778",

publisher = "AME Publishing Company",

}

TY - JOUR

T1 - Updates on the preoperative immunotherapy for triple-negative breast cancer

AU - Hu, Hong

AU - Kaklamani, Virginia

PY - 2023/4/30

Y1 - 2023/4/30

KW - Triple negative breast cancer (TNBC)

KW - immunotherapy

KW - neoadjuvant

KW - pembrolizumab

UR - https://www.scopus.com/pages/publications/85206565557

UR - https://www.scopus.com/pages/publications/85206565557#tab=citedBy

U2 - 10.21037/tbcr-23-16

DO - 10.21037/tbcr-23-16

M3 - Editorial

AN - SCOPUS:85206565557

SN - 2218-6778

VL - 4

JO - Translational Breast Cancer Research

JF - Translational Breast Cancer Research

M1 - 17

ER -